Bilchick Kenneth C, Helm Robert H, Kass David A
Division of Cardiology, Johns Hopkins School of Medicine, Baltimore, MD 21205, USA.
Curr Cardiol Rep. 2007 Sep;9(5):358-65. doi: 10.1007/BF02938362.
Biventricular pacing (cardiac resynchronization therapy ) has been shown to be a very effective therapy for patients with heart failure and dyssynchrony, with improved survival now shown in a recent trial. Electrical dyssynchrony, usually quantified by the duration of the QRS complex, is distinct from mechanical dyssynchrony. Intraventricular mechanical dyssynchrony is most commonly manifest by decreased septal work with concomitant early lateral wall prestretch and subsequent inefficient late contraction. Intraventricular dyssynchrony appears to be more predictive of response to CRT than interventricular dyssynchrony. Mechanical left ventricular dyssynchrony also is associated with regional molecular derangements in connexin-43, stress response kinases, and tumor necrosis factor-alpha. These molecular derangements may lead to abnormalities in conduction velocity and action potential duration, which may predispose to ventricular arrhythmia. Biventricular pacing corrects abnormal regional wall stresses and results in electrical, mechanical, and molecular left ventricular remodeling.
双心室起搏(心脏再同步治疗)已被证明是治疗心力衰竭和不同步的一种非常有效的疗法,最近的一项试验显示其可提高生存率。电不同步通常通过QRS波群的持续时间来量化,与机械不同步不同。心室内机械不同步最常见的表现是室间隔做功减少,同时伴有早期侧壁预拉伸和随后低效的晚期收缩。心室内不同步似乎比心室间不同步更能预测对心脏再同步治疗的反应。机械性左心室不同步还与连接蛋白43、应激反应激酶和肿瘤坏死因子-α中的局部分子紊乱有关。这些分子紊乱可能导致传导速度和动作电位持续时间异常,这可能易引发室性心律失常。双心室起搏可纠正异常的局部壁应力,并导致左心室在电、机械和分子水平上的重塑。